Furthermore, the observed incidence of unequivocal positivity for anti-TG2 and anti-endomysial antibodies points to a frequency of celiac disease in the IgAN and unaffected control groups that is similar to that reported for the general population [27]–[29]. The gene discussed is TGM2; the disease is celiac disease.